Cargando…
The prognostic value of tumor markers doubling times in medullary thyroid carcinoma - preliminary report
INTRODUCTION: Calcitonin (Ct) and carcinoembrional antigen (CEA) are widely used as tumor markers for the post-operative follow-up of patients with medullary thyroid carcinoma (MTC). In patients with elevated serum Ct and CEA their dynamics can be described by calculating the doubling time (DT) - th...
Autores principales: | Gawlik, Tomasz, d'Amico, Andrea, Szpak-Ulczok, Sylwia, Skoczylas, Aleksander, Gubała, Elżbieta, Chorąży, Anna, Gorczewski, Kamil, Włoch, Jan, Jarząb, Barbara |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987862/ https://www.ncbi.nlm.nih.gov/pubmed/21047422 http://dx.doi.org/10.1186/1756-6614-3-10 |
Ejemplares similares
-
Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2017) -
Corrigendum: Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2017) -
Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers – the role of Ct serum level
por: Jarzab, Barbara, et al.
Publicado: (2013) -
Current status of the prognostic molecular markers in medullary thyroid carcinoma
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2020) -
13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study
por: Handkiewicz-Junak, Daria, et al.
Publicado: (2009)